Clinical Trial Update: Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating talnetant versus placebo and risperidone in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)
• Talnetant (talnetant)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED